Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan
· Delayed Price · Currency is TWD 33.10
+0.30 (0.91%)
Apr 29, 2026, 1:17 PM CST
Sofiva Genomics Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 715 | 651 | 863 | 876 | 784 | 1,042 | Upgrade
|
| Market Cap Growth | -19.07% | -24.53% | -1.51% | 11.72% | -24.75% | -4.66% | Upgrade
|
| Enterprise Value | 626 | 579 | 784 | 798 | 684 | 906 | Upgrade
|
| Last Close Price | 33.10 | 30.15 | 39.60 | 40.53 | 35.37 | 45.11 | Upgrade
|
| PE Ratio | - | - | 46.81 | 75.98 | 18.33 | 18.29 | Upgrade
|
| PS Ratio | 1.85 | 1.69 | 1.90 | 1.88 | 1.58 | 2.05 | Upgrade
|
| PB Ratio | 1.14 | 1.04 | 1.34 | 1.42 | 1.25 | 1.67 | Upgrade
|
| P/TBV Ratio | 1.15 | 1.05 | 1.36 | 1.43 | 1.26 | 1.69 | Upgrade
|
| P/FCF Ratio | 50.34 | 45.85 | 48.54 | 325.36 | - | 14.49 | Upgrade
|
| P/OCF Ratio | 46.55 | 42.40 | 24.87 | 36.96 | 45.75 | 13.01 | Upgrade
|
| EV/Sales Ratio | 1.62 | 1.50 | 1.73 | 1.71 | 1.38 | 1.78 | Upgrade
|
| EV/EBITDA Ratio | 20.08 | - | 34.89 | 78.13 | 22.91 | 15.00 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 180.55 | 25.71 | Upgrade
|
| EV/FCF Ratio | 44.08 | 40.79 | 44.10 | 296.41 | - | 12.60 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.08 | 0.10 | 0.12 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 4.52 | 4.52 | 1.40 | 2.50 | 1.60 | 1.11 | Upgrade
|
| Debt / FCF Ratio | 2.50 | 2.50 | 3.00 | 23.62 | - | 1.20 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.14 | -0.14 | -0.12 | -0.15 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | 12.59 | 12.59 | -4.13 | -7.48 | -3.23 | -2.64 | Upgrade
|
| Net Debt / FCF Ratio | -6.28 | -6.28 | -5.22 | -28.40 | 5.87 | -2.21 | Upgrade
|
| Asset Turnover | 0.52 | 0.52 | 0.59 | 0.59 | 0.61 | 0.65 | Upgrade
|
| Inventory Turnover | 7.05 | 7.05 | 7.20 | 6.82 | 7.03 | 7.24 | Upgrade
|
| Quick Ratio | 2.70 | 2.70 | 2.60 | 2.34 | 2.19 | 2.63 | Upgrade
|
| Current Ratio | 3.33 | 3.33 | 3.27 | 2.88 | 2.79 | 3.03 | Upgrade
|
| Return on Equity (ROE) | -1.39% | -1.39% | 3.03% | 1.91% | 6.89% | 9.64% | Upgrade
|
| Return on Assets (ROA) | -2.83% | -2.83% | -0.27% | -1.26% | 0.29% | 2.80% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.13% | -6.19% | -0.50% | -2.96% | 0.69% | 6.98% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.20% | -5.20% | -0.50% | -2.40% | 0.50% | 5.00% | Upgrade
|
| Earnings Yield | -1.31% | -1.44% | 2.14% | 1.32% | 5.46% | 5.47% | Upgrade
|
| FCF Yield | 1.99% | 2.18% | 2.06% | 0.31% | -2.09% | 6.90% | Upgrade
|
| Dividend Yield | 0.89% | - | 0.76% | 0.49% | 2.83% | 4.43% | Upgrade
|
| Payout Ratio | - | - | 23.18% | 185.32% | 99.88% | 52.24% | Upgrade
|
| Buyback Yield / Dilution | 0.23% | 0.23% | -1.28% | 0.04% | -0.40% | 0.43% | Upgrade
|
| Total Shareholder Return | 1.12% | 0.23% | -0.52% | 0.53% | 2.42% | 4.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.